BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


SEARCH JOBS










 Company News
nanoPET Pharma Initiates R&D Partnership With Boehringer Ingelheim Corporation 12/1/2014 3:30:21 PM
Boehringer Ingelheim Corporation, Wellpoint, And HealthCore Announce First Project Under Multi-Year Research Collaboration 11/14/2014 10:58:36 AM
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option 11/13/2014 6:58:48 AM
Boehringer Ingelheim Corporation Release: FDA Study Of Medicare Patients Reaffirms Safety And Efficacy Profile Of Pradaxa® (Dabigatran Etexilate Mesylate) For NVAF 11/3/2014 7:22:35 AM
Hundreds Of New Jobs Coming To Virginia As UniTao Pharma Snaps Up Boehringer Ingelheim Corporation's Old Plant 10/31/2014 6:10:24 AM
Boehringer Ingelheim Corporation Introduces IDBS' E-Workbook Suite 10/28/2014 8:46:07 AM
Boehringer Ingelheim Corporation Presents Data For The Co-Administration Of Two Approved Products For COPD Patients 10/27/2014 8:32:24 AM
Boehringer Ingelheim Corporation Initiates Global Phase 3 Study Investigating Nintedanib In Patients With Colorectal Cancer 10/21/2014 7:17:00 AM
Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev 10/15/2014 3:14:19 PM
Boehringer Ingelheim Corporation And Americares Partner To Expand Product Donations Program Globally 10/15/2014 10:49:17 AM
12345678910...